SEC 13F Intelligence

Propel Bio Management, LLC / SNDX

Propel Bio Management, LLC’s Syndax Pharmaceuticals Inc Position

Does Propel Bio Management, LLC own Syndax Pharmaceuticals Inc (SNDX)? Not currently — the last reported position was 183.3K shares worth $2M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q1 2025
Shares
183.3K
% of Portfolio
+2.62%
Quarters Held
5
position exited

Position History SNDX

Reported value by quarter
Q1 ’24: $2MQ1 ’24Q2 ’24: $2MQ2 ’24Q3 ’24: $3MQ3 ’24Q4 ’24: $2MQ4 ’24Q1 ’25: $2MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2025183.3K$2M+2.62%
Q4 2024183.3K$2M+2.41%
Q3 2024133.3K$3M+1.49%
Q2 202483.3K$2M+1.11%
Q1 202483.3K$2M+1.15%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of SNDX.